AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Pertuzumab in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Perjeta 420 mg Concentrate for Solution for Infusion** Concentrate for solution for infusion | A6-0526 | Roche Products Limited | active | 26 Jun 2029 |
Pertuzumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Pertuzumab, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Pertuzumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.